- Top 10% of respondersArk Biotech is in the top 10% of companies in terms of response time to applications
- Responds within a weekBased on past data, Ark Biotech usually responds to incoming applications within a week
- B2B
- Early StageStartup in initial stages
- Top InvestorsThis company has received a significant amount of investment from top investors
Jobs at Ark Biotech
Ark is building the first high-fidelity bioprocess simulation platform so cutting edge science reaches those who need it most. The cost and timeline to bring new life-saving drugs to market are absurd and only getting worse. Pharma companies years in the wet lab, running hundreds of slow, expensive, experiments, tweaking one variable in the hope that the process will scale. Ark is changing all of that. With the world's highest fidelity bioreactor simulator, scientists can run 1000s of virtual experiments exploring every possible combination of hardware and process controls. We're still early, but already we've demonstrated the ability to optimize yields, improve manufacturability, and get "scale-up" right on the first shot. Biotech insiders say there are probably dozens of life-saving molecules currently sitting on ice, unexplored, because it's just too slow and expensive to develop and test them all. Ark is going to change all of that.
